Archive: 14/12/2021

download6

More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

ZETAGEN THERAPEUTICS AWARDED $2 MILLION USD GRANT FROM THE NATIONAL CANCER INSTITUTE (NCI) FOR PHASE 2 STUDY OF ZETAMET™ FOR TREATMENT OF METASTATIC BONE CANCERS(Zetagen Therapeutics Press Release:  December 13, 2021) Zetagen Therapeutics, Inc., a private, clinical-stage, biopharmaceutical comp...
More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort

Provided  By: PITTSBURGH (PRWEB) DECEMBER 03, 2021Healthcare and life sciences accelerator AlphaLab Health today announced the second cohort of start-up companies to participate in their program. The companies were competitively selected to participate in a six-month program that will help them ...
CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort